CF53
CF53 is a potent, orally bioavailable, and selective BET inhibitor with sub-nanomolar affinity for BRD4 BD1. It demonstrates high selectivity for BET family bromodomains and has shown significant anti-proliferative activity in cellular assays and tumor growth inhibition in animal models, supporting its use in oncology research.
Product Specifications
CAS Number
1808160-52-2
Product Name Alternative
CF53, CF-53, CREBBP, BRDT BD1, BRDT BD2, BRDT-BD1, BRDT-BD2, BRD4-BD1, BRD4-BD2, BRD4 (BD1), BRD4 BD1, BRD4 (BD2), BRD3-BD1, BRD3 BD2, BRD3-BD2, BRD2-BD2, BRD2-BD1, BRD3 BD1, BRD2 BD1, BRD2 BD2, CF 53, CECR2, EP300, Epigenetic Reader Domain, EpigeneticReaderDomain
Field of Research
Cell Biology, Epigenetics & Chromatin
Purity
99.72% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.51 mM) ; DMSO:99 mg/mL (223.22 mM)
Smiles
COc1cc2c (cc1-c1c (C) noc1C) [nH]c1nc (C) nc (Nc3cc (nn3C) C3CC3) c21
Molecular Formula
C24H25N7O2
Molecular Weight
443.5
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
C2266-18A-ML550 100 µL
CD15 (Lewis x, Le x, Hematopoietic Differentiation Antigen, SSEA-1, Stage-specific Embryonic Antigen, X Hapten, 3-fucosyl-N-acetyllactosamine, 3-FAL) (MaxLight 550) discontinued
Sign In for Pricing
View Details 